Researchers discussed preclinical models and drug development for neuromuscular disorders (NMDs) in a panel discussion held at WMS2020.
Highlights of the discussion were as follows:
ニュース WMS 2020 ニュース WMS 2020 神経科学領域の主要な国際・国内学会のハイライト
Drug development for neuromuscular disorders: the essential role of preclinical research
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.